Sensory-Augmented Postural Training for Parkinson's (NCT05982730)
Improve balance using Segway training
- Trial ID
- NCT05982730
- Official Title
- SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease
- Goal
- Improve balance using Segway training
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Texas Southwestern Medical Center
- Study Type
- INTERVENTIONAL
- Enrollment
- 15 participants
- Conditions
- Parkinson Disease
- Interventions
- Sensory-Augmented Postural Training
Summary For Families
The goal is to improve balance and related thinking skills in people with Parkinson's who have moderate balance problems, specifically those at Hoehn and Yahr stage III. The approach uses sensory-augmented postural training on a Segway-like platform, delivering controlled shifts and timed sensory cues that force small posture adjustments to retrain balance reflexes and sensory integration, which may help walking, reduce falls risk, and boost attention. Participants are adults 50 to 85 with idiopathic PD who have been on stable medication at least one month and can stand and walk unsupported for five minutes both on and off medication; people with other neurologic disorders, major unstable illnesses, or sensory or musculoskeletal problems that prevent training are excluded.
Locations
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Sensory-Augmented Postural Training. The goal is to improve balance and related thinking skills in people with Parkinson's who have moderate balance problems, specifically those at Hoehn and Yahr stage III. The approach uses sensory-augmented postural training on a Segway-like platform, delivering controlled shifts and timed sensory cues that force small posture adjustments to retrain balance reflexes and sensory integration, which may help walking, reduce falls risk, and boost attention. Participants are adults 50 to 85 with idiopathic PD who have been on stable medication at least one month and can stand and walk unsupported for five minutes both on and off medication; people with other neurologic disorders, major unstable illnesses, or sensory or musculoskeletal problems that prevent training are excluded.
- Who can participate?
- Participants must be between 50 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 9 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.
- How many visits does this trial involve?
- You will be assessed at 3 time points (1-week before training, before training, and after training) and will receive 1-week of training.